Premier Alternatives

Topo Therapeutics

Cambridge, MA · Founded 2024 · Privately Held (backing)

Operator of small molecule therapeutics intended to accelerate transmembrane protein drug discovery. Topo Therapeutics is based in Cambridge, MA and was founded in 2024. It was valued at $138 million at its early-stage round in Dec 2024, the last priced event on record. It has raised $10.6 million across 1 recorded round; the latest was a $10.6 million early-stage round in Dec 2024.

PMV mark · valuation
$137.6M
Oct 2026
Priced at
its early-stage round
Dec 2024
Total raised
$10.6M
Last round
Early Stage VC
Dec 2024

Topo Therapeutics key facts

as of Oct 2026
  • Operator of small molecule therapeutics intended to accelerate transmembrane protein drug discovery.
  • Topo Therapeutics is valued at approximately $137.6M as of Oct 2026, set at its early-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $10.6M across 1 recorded rounds; the latest was Early Stage VC ($10.6M) in Dec 2024.
  • Notable investors include SR One Capital Management, MRL Ventures Fund, The Column Group.
  • Topo Therapeutics has filed 2 Form Ds with the SEC, most recently Dec 2024 ($10.6M sold to 4 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$137.6M

Valued at $137.6M at its early-stage round, Dec 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Topo Therapeutics with a free account
  • ·Watch Topo Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Topo Therapeutics funding rounds

1 rounds
Dec 2024Early Stage VC$10.6MSEC filing▮
Full funding history →

Topo Therapeutics valuation

Topo Therapeutics was valued at $138 million at its early-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Topo Therapeutics raised?

Topo Therapeutics has raised $10.6 million across 1 recorded round since 2024. The largest was a $10.6 million early-stage round in Dec 2024.

Topo Therapeutics has filed 2 Form Ds with the SEC, most recently in Dec 2024 ($10.6 million sold to 4 investors).

Topo Therapeutics investors

3 investors are on record for Topo Therapeutics, including SR One Capital Management, MRL Ventures Fund and The Column Group. The early-stage round in Dec 2024 drew 4 investors.

About Topo Therapeutics

Operator of small molecule therapeutics intended to accelerate transmembrane protein drug discovery. The company offers transporter and ion channel programs in protein purification, structural determination, and mechanistic assays, enabling hospitals to treat neurological and rare diseases by leveraging novel insights into protein structure and small molecule-protein interactions.

Sector
Healthcare
HQ
Cambridge, MA, United States
Founded
2024
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.